MedPath

Emotion Regulation Intervention to Sustain Physical Activity in Rural-dwelling Women and Men After Myocardial Infarction

Not Applicable
Completed
Conditions
Cardiac Event
Emotions
Interventions
Behavioral: eMotion
Behavioral: Healthy Living Active Control
Registration Number
NCT04441086
Lead Sponsor
Indiana University
Brief Summary

The purpose of this study is to evaluate early preliminary efficacy of the eMotion intervention in US adults who have experienced a first cardiac event and participating in phase II cardiac rehabilitation.

This study will evaluate early efficacy and evaluate the cognitive processes as intervention response variables. Investigators will also examine the relationships between emotion regulation and other cognitive processes and symptoms (threat and stress, cognition and motivation), symptoms \[depression, anxiety, pain, sleep, and fatigue\]), and health related quality of life among adults enrolled in cardiac rehabilitation after a first cardiac event.

Detailed Description

Aim 1: Evaluate early preliminary efficacy of the eMotion intervention

Research hypothesis 1. Compared with adults randomized to active healthy living attention control and usual care control groups, adults randomized to eMotion will have greater improvement in these outcomes over time:

1.1. Improved minutes of moderate to vigorous physical activity 1.2. Symptom improvement (depression, anxiety, pain, sleep, and fatigue) 1.3. Health related quality of life.

Aim 2: Evaluate the cognitive processes as intervention response variables.

Research hypothesis 2. Compared with adults randomized to active healthy living attention control and usual care control groups, adults randomized to eMotion will have:

2.1. Improved emotion regulation (efficiency and strategy use) 2.2. Decreased perceived cardiac threat and general stress 2.3. Improved cognition and motivation

Aim 3. Exploratory. Examine the relationships between emotion regulation and other cognitive processes and symptoms (threat and stress, cognition and motivation), and symptoms \[depression, anxiety, pain, sleep, and fatigue\]) among adults enrolled in cardiac rehabilitation after a first major cardiac event.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
40
Inclusion Criteria
  1. First time major cardiac event as documented in medical record;
  2. enrolled in cardiac rehabilitation phase II program;
  3. living independently; and
  4. at least mild symptoms of depression and/or anxiety (determined by standardized measure cutpoints).

Exclusion criteria:

  1. does not speak English;
  2. major Axis 1 psychiatric diagnosis (e.g. schizophrenia);
  3. terminal cancer; and
  4. legally blind
Read More
Exclusion Criteria

Not provided

Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
eMotioneMotionThe eMotion intervention is based on feasibility testing of the successful in-person program with critical refinement to improve accessibility. eMotion has undergone subsequent content validity testing with intervention development, self-management, cardiovascular health, and health information technology delivery experts. eMotion teaches a carefully selected repertoire of emotion regulation strategies well suited for aging rural adults following a first cardiac event in tandem with usual cardiac rehabilitation. The intervention helps patients recognize their emotions, balance emotional and physical wellbeing, and implement emotion regulation strategies effectively. Intervention provided in addition to usual cardiac rehabilitation.
Healthy living active controlHealthy Living Active ControlHealthy living strategies based on American Heart Association education. Intervention provided in addition to usual cardiac rehabilitation.
Primary Outcome Measures
NameTimeMethod
Change in Moderate to Vigorous Physical Activity (MVPA)1 week trials at baseline, 12 weeks, 20 weeks, and 52 weeks

Minutes spent in MVPA

Secondary Outcome Measures
NameTimeMethod
Change in Fatigue SymptomsBaseline to 12 weeks, 20 weeks, and 52 weeks

Fatigue will be measured using the Fatigue Severity Scale

Change in Depression SymptomsBaseline to 12 weeks, 20 weeks, and 52 weeks

Symptoms of depression measured using the Depression, Anxiety, and Stress Scale (DASS)

Change in Anxiety SymptomsBaseline to 12 weeks, 20 weeks, and 52 weeks

Symptoms of anxiety measured using the Depression, Anxiety, and Stress Scale (DASS)

Change in Pain SymptomsBaseline to 12 weeks, 20 weeks, and 52 weeks

Pain will be measured with the Brief Pain Inventory

Change in Sleep efficiencyBaseline to 12 weeks, 20 weeks, and 52 weeks

Sleep efficiency will be a calculation of the ratio of the total sleep time to time spent in bed using the ActiGraph wGT3X-BT accelerometer

Trial Locations

Locations (4)

Indiana University Health Bedford Hospital

🇺🇸

Bedford, Indiana, United States

Indiana University Health West Hospital

🇺🇸

Avon, Indiana, United States

Indiana University Health Methodist Hospital

🇺🇸

Indianapolis, Indiana, United States

Indiana University Health Tipton Hospital

🇺🇸

Tipton, Indiana, United States

© Copyright 2025. All Rights Reserved by MedPath